- ￥3390
- AntibodySystem
- VMG17603
- 2025年07月13日
- FuncS
- Mouse
- Mouse
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
InVivoMAb Anti-Mouse PD-1 & CD47 Bispecific Antibody (Iv0241)
- 抗体英文名：
InVivoMAb Anti-Mouse PD-1 & CD47 Bispecific Antibody (Iv0241)
- 浓度：
1 mg/ml
- 应用范围：
FuncS
- 宿主：
Mouse
- 适应物种：
Mouse
- 保质期：
1 year
- 级别：
科研级
- 库存：
999
- 供应商：
AntibodySystem
- 克隆性：
Monoclonal
- 亚型：
IgG
- 规格：
100ug
| 宿主 | Mouse |
| 种属反应性 | Mouse |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS, pH 7.4. |
| 浓度 | 1 mg/ml |
| 纯度 | >95% as determined by SDS-PAGE. |
| 克隆类型 | Monoclonal |
| 同种型 | IgG |
| 应用 | FuncS |
| 靶标 | Bispecific, Programmed cell death protein 1, Protein PD-1, mPD-1, CD279, Pdcd1, Pd1, Leukocyte surface antigen CD47, Integrin-associated protein, IAP, CD47, Cd47 |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 内毒素水平 | Please contact with the lab for this information. |
| Accession号 | Q02242 & Q61735 |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| 克隆号 | Iv0241 |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
Our products are designed for various research areas, supporting studies on 48 types of viruses, superbugs, parasites, cancer, Alzheimer's disease, Parkinson's disease, allergic responses, immune suppression, and immune activation.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验How to Make Bispecific Antibodies
of two molecules of Fab’-A(mal) with two free SH-groups at the hinge of a single Fab’-B molecule (see Note 3 ). The remaining free SH groups on Fab’-B are alkylated, and the F(ab’)2 bispecific antibody product (Fab’-A x Fab’-B) is separated by gel filtration
[欢迎下载]：Antibody Engineering： Methods and Protocols
11 Selection of Internalizing Antibodies for Drug Delivery 12 Engineering Multivalent Antibody Fragments for In Vivo Targeting 13 Production of Recombinant Bispecific Antibodies 14 Expression and Isolation of Recombinant Antibody Fragments in E
【翻译】Development trends for monoclonal antibody cancer therapeutics
, after binding to a target, mAbs can recruit effector cells such as natural killer cells, macrophages or neutrophils, or activate complement to destroy the target3, 24, 25, 26, 27. These two modes of action are referred to as antibody-dependent cell cytotoxicity
技术资料暂无技术资料 索取技术资料
